Champions Oncology, Inc.
CSBR
$5.26
-$0.20-3.66%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 59.42M | 57.94M | 58.42M | 56.88M | 56.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.42M | 57.94M | 58.42M | 56.88M | 56.94M |
| Cost of Revenue | 30.90M | 31.36M | 29.15M | 29.31M | 28.39M |
| Gross Profit | 28.52M | 26.58M | 29.28M | 27.57M | 28.56M |
| SG&A Expenses | 20.47M | 19.87M | 18.44M | 17.10M | 16.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.45M | 60.17M | 55.96M | 53.87M | 52.10M |
| Operating Income | -1.03M | -2.22M | 2.46M | 3.01M | 4.85M |
| Income Before Tax | -929.00K | -2.40M | 2.36M | 2.84M | 4.63M |
| Income Tax Expenses | 246.00K | -55.00K | -74.00K | -81.00K | -74.00K |
| Earnings from Continuing Operations | -1.18 | -2.34 | 2.43 | 2.92 | 4.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 61.00K | 61.00K | 61.00K | 30.00K | -- |
| Net Income | -1.11M | -2.28M | 2.49M | 2.95M | 4.70M |
| EBIT | -1.03M | -2.22M | 2.46M | 3.01M | 4.85M |
| EBITDA | 347.00K | -773.00K | 3.97M | 4.56M | 6.49M |
| EPS Basic | -0.08 | -0.17 | 0.18 | 0.22 | 0.34 |
| Normalized Basic EPS | -0.03 | -0.09 | 0.13 | 0.15 | 0.23 |
| EPS Diluted | -0.08 | -0.17 | 0.16 | 0.20 | 0.32 |
| Normalized Diluted EPS | -0.03 | -0.09 | 0.12 | 0.14 | 0.21 |
| Average Basic Shares Outstanding | 55.38M | 55.22M | 55.03M | 54.84M | 54.64M |
| Average Diluted Shares Outstanding | 56.05M | 55.89M | 56.36M | 55.92M | 56.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |